Need help with D and E on problem 6! **Problem 5:**Suppose a cell expresses HK-I and 5 mM is the concentration of glucose in the blood. Compare the cellular concentration of glucose (relative to 5 mM) based on the G6P concentration in the cell being low or high. **Problem 6:**Brain cells express HK-I and liver cells express HK-IV. This differential gene expression is an adaptation of cellular function to the blood glucose concentration, which averages 4-5 mM in a healthy body. Consider the specific conditions as shown in the figure.**Diagram Description:**The diagram illustrates two different types of cells and their respective enzymes and G6P concentrations:- A **brain cell** expresses HK-I and has low G6P concentration.- A **liver cell** expresses HK-IV and has low G6P concentration.Both cells are exposed to a blood glucose concentration of 5 mM.**Questions:****A.** In which cell is the rate of G6P formation greater? Justify your answer.**B.** Which cell has the higher rate of net glucose transport? Justify your answer.**C.** Give a reason to expect high G6P concentration in a cell with high energy charge.**D.** How would the rate of glucose transport into the liver cell change if the energy charge were to become low? Justify your answer.**E.** How would the rate of glucose transport into the brain cell change if the energy charge of the cell were to become high? Justify your answer.

Hexokinase or HK is an enzyme that is responsible for the phosphorylation of six-carbon or hexose…

D. How would the rate of glucose transport into the liver cell change if the energy charge were to become low? Justify your answer. E. How would the rate of glucose transport into the brain cell change if the energy charge of the cell were to become high? Justify your answer.

D. How would the rate of glucose transport into the liver cell change if the energy charge were to become low? Justify your answer. E. How would the rate of glucose transport into the brain cell change if the energy charge of the cell were to become high? Justify your answer.

Basic Clinical Laboratory Techniques 6E

6th Edition

ISBN:9781133893943

Author:ESTRIDGE

Publisher:ESTRIDGE

Chapter6: Basic Clinical Chemistry

Section6.4: Point-of-care Testing

Problem 1RQ

See similar textbooks

Related questions

Q: Which of the following are important aspects of neural coding? "each nerve fiber carries a different…

A: Neural Coding:- It is defined as a sub specialty of neuroscience concerned with study of information…

Q: Identify the coefficients of the correct balanced equation for the reaction, CaCl2 + AGNO3 D AgCl +…

A: The given reaction is, CaCl2(aq)+AgNO3(aq)→ AgCl(s) +Ca(NO3)2(aq).

Q: Which of the following developments made cigarettes dangerous?

A: ANS: OPTION i. ii, ivth are correct...

Q: Use the following balanced equation for problems 1-5. Molar masses are given below. 2 As + 3 H2 2…

A: Balanced chemical equation: This is an equation representing a chemical reaction in which the total…

Q: QUESTION 20 Fentanyl is: O found in Erythroxylon coca O a drug for addiction treatment O a synthetic…

A: Introduction A drug is any chemical substance that alters the physiology or psychology of an…

Q: One of the main functions of the brain is dealing with somatic reflexes True False

A: Given: One of the main functions of the brain is dealing with somatic reflexes.

Q: True or False? Mutations are always harmful to a cell or a virus. O True O False

A: A mutation is considered as a change in a DNA sequence. Mutations can be a result of DNA copying…

Q: The best way to make human protein for drug use is to

A: Proteins are the key factors of most all the functions of a cell. Any impairment in the production…

Q: Each peak on the tandem mass spectrogram represents a product ion with a +1 charge. Use the…

A: Mass spectrometry is an analytical gel-free proteomics method used for identification of proteins,…

Q: QUESTION 30 Which of the following properties of the cochlea is related to so-called "labeled line"…

A: Labeled line coding is a hypothesis to explain how different nerves all of which use the same…

Q: Match the following brain parts with their main regions of location primary motor cortex A. frontal…

A: The cerebral cortex is the outermost layer of the brain that provides it with its distinctive…

Q: Write the Structure Activity Relationship (SAR) of Barbiturates? Please write at your own words.

A: Barbiturates are chemicals that are used as drugs for the depressing of the central nervous system.…

Q: Which of the following best describes an ion channel? Operates like a kind of valve O Switches off…

A: Ion channels refer to the membrane proteins that form the pore, which allows the passage of ions…

Concept explainers

Immune Disorders

The collaboration between the cells and proteins that work together as a defense system against infection comprises the immune system.Each of them performs a variety of tasks to recognize and/or react against a foreign body.

Question

Need help with D and E on problem 6!

**Problem 5:**
Suppose a cell expresses HK-I and 5 mM is the concentration of glucose in the blood. Compare the cellular concentration of glucose (relative to 5 mM) based on the G6P concentration in the cell being low or high.

**Problem 6:**
Brain cells express HK-I and liver cells express HK-IV. This differential gene expression is an adaptation of cellular function to the blood glucose concentration, which averages 4-5 mM in a healthy body. Consider the specific conditions as shown in the figure.

**Diagram Description:**
The diagram illustrates two different types of cells and their respective enzymes and G6P concentrations:
- A **brain cell** expresses HK-I and has low G6P concentration.
- A **liver cell** expresses HK-IV and has low G6P concentration.

Both cells are exposed to a blood glucose concentration of 5 mM.

**Questions:**

**A.** In which cell is the rate of G6P formation greater? Justify your answer.

**B.** Which cell has the higher rate of net glucose transport? Justify your answer.

**C.** Give a reason to expect high G6P concentration in a cell with high energy charge.

**D.** How would the rate of glucose transport into the liver cell change if the energy charge were to become low? Justify your answer.

**E.** How would the rate of glucose transport into the brain cell change if the energy charge of the cell were to become high? Justify your answer.

Expert Solution

This question has been solved!

Explore an expertly crafted, step-by-step solution for a thorough understanding of key concepts.

This is a popular solution!

SEE SOLUTION Check out a sample Q&A here

Step 1

VIEW

Step 2

VIEW

Trending now

This is a popular solution!

Step by step

Solved in 2 steps

SEE SOLUTION Check out a sample Q&A here

Knowledge Booster

Learn more about

Need a deep-dive on the concept behind this application? Look no further. Learn more about this topic, biology and related others by exploring similar questions and additional content below.

Similar questions

Targeted therapies are used in patients with a set gene expression pattern. A targeted therapy that prevents the activation of the estrogen receptor in breast cancer would be beneficial to which type of patient? patients who express the EGFR receptor in normal cells patients with a mutation that inactivates the estrogen receptor patients with lots of the estrogen receptor expressed in their tumor patients that have no estrogen receptor expressed in their tumor
b. Compounds A, B, C, and D are known to be intermediates in the pathway for production of protein E. To determine where the block in protein-E production occurred in each individual, the various intermediates were given to each individuals cel Is in culture. After a few weeks of growth with the intermediate, the cells were assayed for the production of protein E. The results for each individuals cells are given in the following table. A plus sign means that protein E was produced after the cells were given the intermediate listed at the top of the column. A minus sign means that the cells still could not produce protein E even after being exposed to the intermediate at the top of the column. Denote the point in the pathway in which each individual is blocked.
a. Compounds A, B, C, and D are known to be intermediates in the pathway for production of protein E. To determine where the block in protein-E production occurred in each individual, the various intermediates were given to each individuals cel Is in culture. After a few weeks of growth with the intermediate, the cells were assayed for the production of protein E. The results for each individuals cells are given in the following table. A plus sign means that protein E was produced after the cells were given the intermediate listed at the top of the column. A minus sign means that the cells still could not produce protein E even after being exposed to the intermediate at the top of the column. Draw the pathway leading to the production of protein E.
Two genes associated with breast cancer, BRCA1 and BRCA2, were discovered in 1994 and 1995, respectively, and shortly thereafter, were patented by Myriad Genetics, a company based in Utah. Under the patents, testing for mutations in these genes could only be performed by Myriad, at costs from 300 to 3,000. Myriad also patented the process of analyzing the results of such tests, preventing anyone who obtains the sequence of their BRCA genes by other means (which itself would probably be patent infringement) from interpreting the information. The idea that genes can be patented has been a contentious issue from the beginning. Patents are not granted for products of nature, meaning that genes inside the body are not patentable, but biotech companies successfully argued that by removing a gene from the human body, purifying it, and then obtaining its DNA sequence, they created something not found in nature, and which is therefore a patentable invention. The U.S. Patent Office found the argument persuasive, but opponents argue that genes are parts of our bodies and can be identified but not invented. Biotech companies argue that without the protection offered by patents, they would have no incentive for research and development of diagnostic tests. In Europe, patents for BRCA1 and BRCA2 were revoked in 2004 because they did not meet the standards for a patent. After more than a decade of legal disputes, the patents were partially restored in 2008 on a very restricted basis. In the United States, a lawsuit, focused on the patents for the BRCA genes, was filed in May 2009. The suit challenges the basic idea that genes are patentable. In November 2009, the judge ruled that the lawsuit can proceed, and the case is moving forward. In March 2010, a federal court invalidated Myriad Genetics patent on these genes. In August 2011, the U.S. Court of Appeals reversed the lower courts decision and ruled that gene sequences isolated from cells are not a product of nature and are therefore patentable. The case went to the U.S. Supreme Court, which ordered the appeals court to reconsider the case. The Federal Appeals Court did not change its decision, and the case once again, went to the U.S. Supreme Court. A unanimous decision in June 2013 invalidated Myriads patents on the basis that isolating a gene from nature does not make it patentable. This is a landmark decision on gene patenting with widespread ramifications for the biotechnoloogy industry. Will this decision reduce the incentives for companies to invest in new diagnostic tests that would be used by cancer victims or those with serious genetic disorders?
More than 500 genes have been identified in the human genome that code for protein kinases. What does such identification imply regarding the role of protein kinases in cellular functions? Explain your answer.
INTERPRET DATA Develop a simple hypothesis that would explain the behavior of each of the following types of mutants in E. coli. Mutant a: The map position of this mutation is in the trp operon. The mutant cells are constitutive; that is, they produce all the enzymes coded for by the trp operon, even if large amounts of tryptophan are present in the growth medium. Mutant b: The map position of this mutation is in the trp operon. The mutant cells do not produce any enzymes coded for by the trp operon under any conditions. Mutant c: The map position of this mutation is some distance from the trp operon. The mutant cells are constitutive; that is, they produce all the enzymes coded for by the trp operon, even if the growth medium contains large amounts of tryptophan.
The cystic fibrosis gene encodes a chloride channel protein necessary for normal cellular functions. Let us assume that if at least 5% normal channels are present, the affected individual has mild symptoms of cystic fibrosis. Having less than 5% normal channels produces severe symptoms. At least 50% of the channels must be expressed for the individual to be phenotypically normal. This gene has various mutant recessive alleles: Predict the percent of functional channels and severity of symptoms for the following genotypes: a. heterozygous for CF100 b. homozygous for CF100 c. heterozygous, with one copy of CF100 and one of CF3 d. heterozygous, with one copy of CF1 and one copy of CF3
Protein modification can alter gene expression in many ways. Describe how phosphorylation of proteins can alter gene expression.
Two types of mutations discussed in this chapter are (1) nucleotide changes and (2) unstable genome regions that undergo dynamic changes. Describe each type of mutation.
Achondroplasia is an autosomal dominant form of dwarfism caused by a single gene mutation. Calculate the mutation rate of this gene given the following data: 10 achondroplastic births to unaffected parents in 245,000 births.
Which of the following analogies best describes the induced-fit model of enzyme-substrate binding? a hug between two people a key fitting into a lock a square peg fitting through the square bole and a round peg fitting through the round hole of a children’s toy the fitting together of two jigsaw puzzle pieces
Pedigree Analysis Is a Basic Method in Human Genetic: What does OMIM stand for? What kinds of information are in this database?